These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6118155)

  • 1. Characterization of alpha-adrenergic receptors in rat lung membranes: presence of alpha 1 but not alpha 2 receptors.
    Latifpour J; Bylund DB
    Biochem Pharmacol; 1981 Sep; 30(18):2623-5. PubMed ID: 6118155
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-adrenergic receptors in the rat superior cervical ganglion.
    Kafka MS; Thoa NB
    Biochem Pharmacol; 1979 Aug; 28(16):2485-9. PubMed ID: 41530
    [No Abstract]   [Full Text] [Related]  

  • 3. [3H]Dihydroergocryptine binding to alpha adrenergic receptors in canine aortic membranes.
    Tsai BS; Lefkowitz RJ
    J Pharmacol Exp Ther; 1978 Mar; 204(3):606-14. PubMed ID: 24730
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization by [3H]dihydroergocryptine binding of alpha-adrenergic receptors in neuroblastoma X glioma hybrid cells.
    Haga T; Haga K
    J Neurochem; 1981 Mar; 36(3):1152-9. PubMed ID: 6110704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for two alpha-adrenergic binding sites in liver plasma membranes. Studies with [3H]epinephrine and [3H]dihydroergocryptine.
    El-Refai MF; Blackmore PF; Exton JH
    J Biol Chem; 1979 Jun; 254(11):4375-86. PubMed ID: 35537
    [No Abstract]   [Full Text] [Related]  

  • 6. Human platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand.
    Daiguji M; Meltzer HY; U'Prichard DC
    Life Sci; 1981 Jun; 28(24):2705-17. PubMed ID: 6115296
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha noradrenergic receptors in rat brain membranes.
    Greenberg DA; Snyder SH
    Mol Pharmacol; 1978 Jan; 14(1):38-49. PubMed ID: 203845
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and characterization of alpha 1 adrenergic receptors in rat myocardium with a new iodinated radioligand, [125I]IBE 2254.
    Steinberg SF; Bilezikian JP
    J Mol Cell Cardiol; 1982 Oct; 14(10):601-10. PubMed ID: 6130159
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of [3H]clonidine and [3H]WB4101 to the pre- and postsynaptic alpha-adrenoceptors of the basal hypothalamus of the starved male rat.
    Spyra B; Pirke KM
    Brain Res; 1982 Aug; 245(1):179-82. PubMed ID: 6126263
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P; Meyer P
    Br J Pharmacol; 1981 May; 73(1):33-9. PubMed ID: 6269682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha-adrenergic mediated effect in rat liver. Correlation between [3H]-dihydroergocryptine binding to plasma membranes and glycogen phosphorylase activation in isolated hepatocytes.
    Aggerbeck M; Guellaen G; Hanoune J
    Biochem Pharmacol; 1980 Jun; 29(12):1653-62. PubMed ID: 6250542
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-adrenergic receptors in the rat superior cervical ganglion.
    Kafka MS; Horn JP; Thoa NB; McAfee DA
    Ann N Y Acad Sci; 1980; 358():342-5. PubMed ID: 6259995
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.
    Greengrass P; Bremner R
    Eur J Pharmacol; 1979 May; 55(3):323-6. PubMed ID: 37098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function.
    Peroutka SJ; Greenberg DA; U'Prichard DC; Snyder SH
    Mol Pharmacol; 1978 May; 14(3):403-12. PubMed ID: 26861
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of alpha-adrenergic receptors in guinea-pig vas deferens by [3H]dihydroergocryptine binding.
    Holck MI; Marks BH; Wilberding CA
    Mol Pharmacol; 1979 Jul; 16(1):77-90. PubMed ID: 225655
    [No Abstract]   [Full Text] [Related]  

  • 16. Identical antagonist selectivity of central and peripheral alpha 1-adrenoceptors.
    Timmermans PB; Ali FK; Kwa HY; Schoop AM; Slothorst-Grisdijk FP; van Zwieten PA
    Mol Pharmacol; 1981 Sep; 20(2):295-301. PubMed ID: 6117785
    [No Abstract]   [Full Text] [Related]  

  • 17. An assay for alpha-adrenergic receptor subtypes using [3H]dihydroergocryptine.
    Hoffman BB; Lefkowitz RJ
    Biochem Pharmacol; 1980 Feb; 29(3):452-4. PubMed ID: 6244840
    [No Abstract]   [Full Text] [Related]  

  • 18. The binding of fluorocatecholamines to adrenergic and dopaminergic receptors in rat brain membranes.
    Nimit Y; Cantacuzene D; Kirk KL; Creveling CR; Daly JW
    Life Sci; 1980 Oct; 27(17):1577-85. PubMed ID: 6255279
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of alpha-adrenergic receptor subtypes in rat brain: estimation of ability of adrenergic ligands to displace 3H-dihydroergocyrptine from the receptor subtypes.
    Haga T; Haga K
    Life Sci; 1980 Jan; 26(3):211-8. PubMed ID: 6244473
    [No Abstract]   [Full Text] [Related]  

  • 20. Receptor interaction for the alpha-antagonist WB4101 (2(N[2,6-dimethyoxyphenoxyethyl])amino-methyl-1,4-benzodioxane).
    Kapur H; Mottram DR; Green PN
    J Pharm Pharmacol; 1978 Apr; 30(4):259-60. PubMed ID: 24721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.